Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
The Best Lawyers in America®
Read More +The National Law Journal
Read More +September 26, 2023 - 9:00AM EDT
Successfully represented French steelmakers Sollac and Ugine (then subsidiaries of Usinor, now Arcelor) against AK Steel’s accusation that Sollac infringed six patents relating to aluminum-coated stainless steel, which is highly desirable and profitable for automotive applications due to its appearance and corrosion resistance. Despite defending against this six-patent attack in Ohio, AK’s home state and the heart of America’s steel industry, Sollac defeated AK with respect to all six patents after district court and appellate court proceedings. Due to the strength of this victory, Sollac then received a monetary settlement from patentee AK to resolve a related antitrust countersuit. AK Steel v. Sollac, 344 F.3d 1234 ((Fed. Cir. 2003).
Represented Orion Corporation Fermion against Tanabe Seiyaku Co. and Marion Merrel Dow Inc. in a case claiming patent infringement involving diltiazem. At the Federal Circuit, the ITC’s finding of no infringement was affirmed. Tanabe Seiyaku Co. v. U.S. International Trade Commission, 109 F.3d 726 (Fed. Cir. 1997).